Security National Bank of So Dak’s Alnylam Pharmaceuticals ALNY Stock Holding History

Security National Bank of So Dak’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$662K	Hold	2,000	–	–	0.32%	73
2025 Q4	$795K	Hold	2,000	–	–	0.39%	63
2025 Q3	$912K	Hold	2,000	–	–	0.46%	63
2025 Q2	$652K	Hold	2,000	–	–	0.36%	69
2025 Q1	$540K	Hold	2,000	–	–	0.31%	72
2024 Q4	$471K	Hold	2,000	–	–	0.26%	75
2024 Q3	$550K	Hold	2,000	–	–	0.31%	69
2024 Q2	$486K	Hold	2,000	–	–	0.29%	70
2024 Q1	$299K	Hold	2,000	–	–	0.18%	86
2023 Q4	$383K	Hold	2,000	–	–	0.25%	73
2023 Q3	$354K	Hold	2,000	–	–	0.26%	77
2023 Q2	$380K	Buy	+2,000	New	+$397K	0.27%	73
2022 Q4	$475K	Hold	2,000	–	–	0.34%	66
2022 Q3	$400K	Hold	2,000	–	–	0.36%	70
2022 Q2	$292K	Hold	2,000	–	–	0.24%	79
2022 Q1	$327K	Buy	2,000 +500	+33%	+$76.2K	0.23%	80
2021 Q4	$254K	Hold	1,500	–	–	0.17%	90
2021 Q3	$283K	Buy	+1,500	New	+$281K	0.22%	83
2021 Q2	–	Sell	-1,500	Closed	-$212K	–	98
2021 Q1	$212K	Buy	+1,500	New	+$226K	0.18%	93
2020 Q4	–	Sell	-1,500	Closed	-$218K	–	89
2020 Q3	$218K	Hold	1,500	–	–	0.22%	80
2020 Q2	$222K	Buy	+1,500	New	+$202K	0.25%	72
2017 Q4	–	Sell	-2,100	Closed	-$247K	–	93
2017 Q3	$247K	Buy	+2,100	New	+$179K	0.28%	81

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Security National Bank of So Dak's ALNY Position: Q1 2026 in Review

Security National Bank of So Dak held its Alnylam Pharmaceuticals (ALNY) position steady in Q1 2026 at 2,000 shares worth $662K. The position accounts for 0.32% of the portfolio, ranked #73.

Security National Bank of So Dak first reported a position in ALNY in Q3 2017 and has held it in 22 quarters since. The position peaked at $912K in Q3 2025. 787 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

Security National Bank of So Dak held 2,000 shares of Alnylam Pharmaceuticals worth $662K as of Q1 2026.
Security National Bank of So Dak left its Alnylam Pharmaceuticals share count unchanged in Q1 2026.
Alnylam Pharmaceuticals made up 0.32% of Security National Bank of So Dak's portfolio in Q1 2026, its #73 holding.
Security National Bank of So Dak first reported a position in Alnylam Pharmaceuticals in Q3 2017 and has held it in 22 quarters since.
Security National Bank of So Dak's Alnylam Pharmaceuticals position peaked at $912K in Q3 2025.
787 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Security National Bank of So Dak's 13F filing for Q1 2026, filed 15 May 2026.